Read the latest positive news, breakthroughs, and inspiring stories about flu prevention, curated daily by BrightWire.
The FDA just approved America's first mRNA flu vaccine for people 50 and older, bringing the same technology that powered COVID vaccines to seasonal flu prevention. The shot could arrive in pharmacies this fall, offering better protection through faster strain matching.
The FDA just approved the nation's first mRNA flu vaccine, offering millions of older Americans stronger protection against the flu starting in 2026. The groundbreaking shot could pave the way for a future where one seasonal jab protects against multiple respiratory viruses at once.
A breakthrough flu vaccine using the same technology that helped end the COVID-19 pandemic just cleared a major hurdle, potentially offering faster protection for millions of seniors. The FDA's expert panel unanimously recommended approval of Moderna's mRNA flu shot for Americans over 50.
A new flu vaccine that works 27% better than standard shots won unanimous support from FDA advisors, marking a comeback after political interference nearly blocked its review. The mRNA platform could transform how we fight future flu pandemics.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
A new type of flu shot using mRNA technology just cleared a major hurdle, bringing us closer to better protection against seasonal flu. The same groundbreaking approach that powered COVID vaccines could soon help millions stay healthier each winter.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
After an unexpected rejection last week, the FDA has reversed course and agreed to review Moderna's new mRNA flu vaccine. Seniors could have a new option to protect against the flu by late 2026.
A twice-daily nasal spray could shield people from any type of flu virus, including pandemic strains that jump from animals to humans. Early human trials show the antibody spray works safely and reaches the exact spot where flu enters our bodies.
New research shows people with low vitamin D face 33% higher hospitalization rates for respiratory infections. The discovery offers a simple way to strengthen your immune system during flu season.
Winter brings more than cozy sweaters and hot cocoa. Senior doctors reveal simple, science-backed habits that can protect you from seasonal flu and pneumonia this year.
Scientists placed flu patients and healthy people together indoors for two weeks, expecting infections. Zero people got sick, revealing that ventilation and fewer coughs may matter more than close contact.
